What happened Shares of Compugen (NASDAQ: CGEN) were jumping 9.1% higher as of 11:59 a.m. EDT on Wednesday. The big gain came after the clinical-stage drugmaker provided its second-quarter update. So what This wasn't a case where a biotech stock soared after posting tremendous revenue growth in its quarterly results.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting